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Summary 
We have identified a human homolog of the bacterial 
MutS and S. cerevisiae MSH proteins, called hMSH2. 
Expression of hMSH2 in E. coli causes a dominant mu- 
tator phenotype, suggesting that hMSH2, like other 
divergent MutS homologs, interferes with the normal 
bacterial mismatch repair pathway. hMSH2 maps to 
human chromosome 2~22-21 near a locus implicated 
in hereditary nonpolyposis colon cancer (HNPCC). A 
T to C transition mutation has been detected in the 
-6 position of a splice acceptor site in sporadic colon 
tumors and in affected individuals of two small HNPCC 
kindreds. These data and reports indicating that S. cer- 
evisiae msh2 mutations cause an instability of dinucle- 
otide repeats like those associated with HNPCC sug- 
gest that hMSH2 is the HNPCC gene. 
Introduction 
The faithful transmission of genetic information is para- 
mount to the survival of a cell, an organism, and a species. 
Cells have evolved a number of mechanisms to ensure 
the high fidelity transmission of genetic material from one 
generation to the next since mutations can lead to geno- 
types that may be deleterious to the cell. The DNA lesions 
that lead to mutations are most frequently modified, miss- 
ing, or mismatched nucleotides (Friedberg, 1985), and 
multiple enzymatic pathways have been described that 
specifically repair these lesions (Friedberg, 1990). 
There are at least three ways in which mismatched nu- 
cleotides arise in DNA. First, physical damage to the DNA 
can give rise to mismatched bases (Friedberg, 1985). For 
example, the deamination of 5methylcytosine creates a 
thymine and, therefore, a G.T mispair (Duncan and Miller, 
1980). Second, misincorporation of nucleotides during 
DNA replication can yield mismatched base pairs and nu- 
cleotide insertions and deletions (Modrich, 1991). Finally, 
genetic recombination produces regions of heteroduplex 
DNA that may contain mismatched nucleotides when such 
heteroduplexes result from the pairing of two different pa- 
rental DNA sequences (Holliday, 1964). Mismatched nu- 
cleotides produced by each of these mechanisms are 
known to be repaired by specific enzyme systems 
(Friedberg, 1990; Modrich, 1991). 
The best-defined mismatch repair pathway is the Esche- 
richia coli MutHLS pathway that promotes a long patch 
(approximately 2 kb) excision repair reaction that isdepen- 
dent on the m&H, mutl, mutS, and mutU (uvrD) gene prod- 
ucts (Modrich, 1989,199l). The MutHLS pathway appears 
to be the most active mismatch repair pathway in E. coli 
and is known both to increase the fidelity of DNA replica- 
tion (Rydberg, 1978) and to act on recombination interme- 
diates containing mispaired bases (Wagner and Mesel- 
son, 1978; Fishel et al., 1988). This system has been 
reconstituted in vitro and requires the MutH, MutL, MutS, 
and UvrD (helicase II) proteins along with DNA polymerase 
Ill holoenzyme, DNA ligase, single-stranded DNA-binding 
protein, and one of the single-stranded DNAexonucleases 
(Exol, ExoVII, or RecJ) (Modrich, 1989, 1991; Lahue et 
al., 1989; Cooper et al., 1993). MutS protein binds to the 
mismatched nucleotides in DNA (Su and Modrich, 1986). 
MutH protein interacts with GATC sites in DNA that are 
hemimethylated on the adenine and is responsible for inci- 
sion on the unmethylated strand (Welsh et al., 1987). Spe- 
cific incision of the unmethylated strand results in in- 
creased fidelity of replication because excision repair is 
targeted to the newly replicated unmethylated DNA 
strand. MutL facilitates the interaction between MutS 
bound to the mismatch and MutH bound to the hemimethy- 
lated Dam site, resulting in the activation of MutH (Grilley 
et al., 1989). UvrD is the helicase that appears to act in 
conjunction with one of the single-stranded DNA-specific 
exonucleases to excise the unmethylated strand, leaving 
a gap that is repaired by the action of DNA polymerase 
Ill holoenzyme, single-stranded DNA-binding protein, and 
DNA ligase (Matson and George, 1987; Modrich, 1989, 
1991; Lahue et al., 1989; Cooper et al., 1993). In addition, 
E. coli contains several short patch repair pathways (Fishel 
and Kolodner, 1989) including the very short patch (VSP) 
system (Lieb, 1987; Dzidic and Radman, 1989) and the 
MutY (MicA)system(Auet al., 1988; Radicellaet al., 1988), 
which act on specific single base mispairs. 
While genetic studies on gene conversion in fungi were 
the first to suggest the existence of mismatch repair (Holli- 
day, 1964) less is known about the enzymology of mis- 
match repair in eukaryotes than in prokaryotes. Genetic 
analysis suggests that Saccharomyces cerevisiae has a 
mismatch repair system similar to the bacterial MutHLS 
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system (Williamson et al., 1985; Bishop et al., 1987; 
Reenan and Kolodner, 1992a, 1992b), even though S. cer- 
evisiae lacks the type of DNA methylation that directs the 
strandedness of the MutHLS system (Proffitt et al., 1984). 
The S. cerevisiae pathway has a MutS homolog, MSHP 
(Reenan and Kolodner, 1992a, 1992b), and, unlike the 
bacterial systems, two MutL homologs, PMSl (Kramer et 
al., 1989) and MLHl (Strand et al., 1993), that act in the 
same pathway. MSH2 has been shown to bind DNA con- 
taining mismatched nucleotides as predicted from its evo- 
lutionary relationship to the bacterial MutS proteins 
(Reenan and Kolodner, 1992a, 1992b; E. Alani, N.-W. Chi, 
and R. K., unpublished data). However, little is known 
about the other proteins that function in this pathway. S. 
cerevisiae has also been shown to contain other mismatch 
repair systems, including a mitochondrial mismatch repair 
system involving another MutS homolog, MSHl, which 
binds mismatched nucleotides (Reenan and Kolodner, 
1992a, 1992b; N.-W. Chi and R. K., unpublished data). In 
addition, two other MutS homologs have been found in 
S. cerevisiae, MSH3 (New et al., 1993) and MSH4 (P. 
Ross-Macdonald and G. S. Roeder, unpublished data), 
although these two proteins are unlikely to play a major 
role in mismatch repair. 
Biochemical studies have also provided evidence that 
eukaryotes have similar mismatch repair systems. Ex- 
tractsof human (Holmes et al., 1990; Thomaset al., 1991) 
Drosophilia (Holmes et al., 1990) and Xenopus (Varlet et 
al., 1990) cells can catalyze a mismatch repair reaction 
that resembles the bacterial MutHLS system. In addition, 
biochemical studies have found that human cells contain 
a nucleotide-specific mismatch repair system that appears 
to specifically recognize and repair G.T mispairs (Wie- 
bauer and Jiricny, 1989,199O). This latter system is similar 
to the E. coli MutY (MicA) system in that it involves a mis- 
pair-specific DNA glycosylase (Au et al., 1989; Wiebauer 
and Jiricny, 1989, 1990). 
In both bacteria and S. cerevisiae, mismatch repair 
plays additional roles in maintaining the genetic stability 
of DNA. The bacterial MutHLS system has been found 
to prevent genetic recombination between the divergent 
DNA sequences of related species such as E. coli and 
Salmonella typhimurium (termed homeologous recombi- 
nation) (Rayssiguier et al., 1989). A similar effect has been 
shown in S. cerevisiae, although the magnitude of the 
effect is not as large as that seen with bacteria (Bailis and 
Rothstein, 1990). Furthermore, genetic studies suggest 
that S. cerevisiae MSH2/PMSl-dependent mismatch re- 
pair controls the length of genetic exchanges (Alani et al., 
1994). In this system, the length of heteroduplex regions 
formed during recombination appears to depend on the 
extent of mispairing between the two recombining se- 
quences. Finally, S. cerevisiae msh2, pmsl, and m/h7 mu- 
tants have been found to exhibit increased rates of expan- 
sion and contraction of dinucleotide repeat sequences 
(Strand et al., 1993). This observation is of particular inter- 
est since different types of human tumors show an analo- 
gous instability of repeated DNA sequences (lonov et al., 
1993; Thibodeau et al., 1993; Han et al., 1993; Risinger et 
al., 1993) and since hereditary nonpolyposis colon cancer 
(HNPCC) (also known as Lynch syndrome II [Bishop and 
Thomas, 1990; Lynch et al., 19911) is linked to a locus 
causing a similar genetic instability (Aaltonen et al., 1993; 
Peltomaki et al., 1993). 
We describe here the cloning and initial characterization 
of a human MutS homolog, hMSH2, and demonstrate that 
the gene maps to human chromosome 2~22-21, a region 
near the reported location of the HNPCC locus (Peltomaki 
et al., 1993). The similarity between S. cerevisiae msh2 
mutants and HNPCC patients with regard to the instability 
of dinucleotide repeat sequences, the correspondence of 
the map locations of HNPCC and the hMSH2 gene, and 
the detection of a specific mutation in small HNPCC kin- 
dreds, as well as sporadic colorectal tumors, suggest that 
mutations in the hMSH2 gene are responsible for HNPCC. 
Results 
Cloning the Human MutS Homolog 
To clone the hMSH2 gene, we utilized the degenerate poly- 
merase chain reaction (PCR) approach that was success- 
ful in the identification of the S. cerevisiae MutS homologs 
MSHl and MSH2 (Reenan and Kolodner, 1992a). Degen- 
erate oligonucleotide primers were designed to target the 
amino acid sequences TGPNM and F(ATV)TH(FY), pres- 
ent in the most conserved regions of the known MutS ho- 
mologs. One primer was used to target the invariant 
TGPNM sequence, whereas three primers were used indi- 
vidually to target FATH(FY), FVTH(FY), and FlTH(FY). 
The FATH(FY) sequence was of particular interest be- 
cause it was most specific to the bacterial and S. cerevis- 
iae homologs known to be involved in the major mismatch 
repair pathways in these organisms. These primers were 
used in a PCR containing human cDNA prepared from 
poly(A)+ RNA as template. PCR conditions were optimized 
to produce maximal yields of the expected 360 bp frag- 
ment, using both S. cerevisiae DNA and human cDNA as 
template. The resulting 360 bp fragment was then purified, 
and a number of independent clones were obtained and 
sequenced. One clone was identified using the FATH(FY) 
primer that contained an open reading frame encoding a 
predicted amino acid sequence that had 81% identity with 
the S. cerevisiae MSH2 protein and had an additional 10% 
conserved amino acid substitution. This cloned segment 
was used as a probe to screen a human cDNA library, 
and several apparent full-length cDNA clones were identi- 
fied. A representative full-length clone had a31 11 bp insert 
that contained a 2727 bp open reading frame (Figure 1). 
This open reading frame, when translated, was found po- 
tentially to encode a 909 amino acid long protein that had 
41% identity with the 966 amino acid S. cerevisiae MSH2 
protein (Figure 2). The most conserved region, located 
between amino acids 573-764 of the human protein, was 
85% identical to the corresponding region of the S. cere- 
visiae protein. 
hMSH2 Is a Member of the MutS Mismatch Repair 
Protein Superfamily 
Comparison of the hMSH2 amino acid sequence with the 
other known MutS homologs showed that it was most 
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Figure 1. Sequence of the hMSH2 cDNA 
The complete DNA sequence of the bMSH2 
cDNA is given, starting with the first nucleotide 
present after the vector polylinker sequence 
and ending after the end of the poly(A) se- 
quence found in the insert. Numbering is from 
the first nucleotide. Presented below the DNA 
sequence is the predicted hMSH2 amino acid 
sequence in single letter code, starting with the 
first in-frame methionine. The protein se- 
quences targeted by the degenerate PCR prim- 
ers are indicated by underlining. 
highly related to S. cerevisiae MSH2 (Reenan and Ko- 
lodner, 1992a) and that these two amino acid sequences 
are more highly related than many pairs of the bacterial 
sequences (Figure 3). The evolutionary relationship 
among all of the known MutS-related proteins indicates 
that hMSH2 is a member of a group of MutS homologs 
that includes all of the bacterial homologs and S. cerevis- 
iae MSHl and MSH2. This group of proteins contains all 
of the members known to play a role in mismatch repair 
and in which mutations of the respective genes have been 
found to cause a strong mutator phenotype in these re- 
spective organisms. 
Expression of hMSH2 Causes a Dominant Mutator 
Phenotype in E. coli 
Expression of a divergent member of the bacterial MutS 
protein family in E. coli has been shown to cause a domi- 
nant mutator phenotype (Prudhomme et al., 1991). Con- 
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Figure 2. Alignment of the Human and S. cerevisiae MSHP Protein Sequences 
Amino acid identities are indicated by stippled boxes, conservative substitutions are indicated by bullets, and gaps are indicated by dashes. 
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Figure 3. Phylogenetic Tree of MutS-Related Proteins 
All protein sequences except S. cerevisiae MSH4 were retrieved from 
NCBllGenBank release 78. The MSH4 sequence was provided by 
P. Ross-Macdonald and G. S. Roeder (Yale University, New Haven, 
Connecticut). The first 21 amino acids of S. cerevisiae MSHI encoding 
the mitochondrial targeting sequence was removed from the MSHl 
sequence prior to construction of the phylogenetic tree. We believe 
this sequence is unrelated to the enzymatic function of the MutS-like 
proteins and that its presence significantly alters the outcome of the 
alignment. 
ceivably, the heterologous protein interacts with mis- 
matched nucleotides but cannot interact with other 
proteins in the repair pathway, thus interfering with normal 
mismatch repair. To gain an insight into whether hMSH2 
plays a role in mismatch repair, the hMSH2 protein was 
expressed in E. coli under control of the lac promoter pres- 
ent in plasmid pMSHl1, and the resulting cells were tested 
for an increased rate of accumulation of ampicillin plus 
rifampicin (rifl) mutations. Mutations of E. coli that result 
in fif’have been mapped to the B subunit of RNA polymer- 
ase and have generally been found to have no effect on 
cell growth or viability (Nene and Glass, 1982). Typical 
results of this mutator assay are shown in Figure 4. These 
results suggest that E. coli cells expressing hMSH2 accu- 
mulate rif’ mutations at a higher rate than the isogenic 
wild-type strain containing the vector alone. Fluctuation 
analysis (Lea and Coulson, 1949) indicates that wild-type 
E. coli has arif’mutation rateof 1.4 x 10mg, that an isogenic 
strain of E. coli containing a mutS mutation has a rif’ muta- 
tion rate of 4.8 x lo-‘, and that the wild-type E. coli ex- 
pressing hMSH2 has a rif’ mutation rate of 1.2 x 1 O+‘. 
Thus, expression of hMSH2 in E. coli results in an approxi- 
mate 1 O-fold higher mutation rate. This observation is con- 
sistent with the idea that the hMSH2 protein can interact 
with mismatched nucleotides but lacks the ability to inter- 
act with other proteins in the E. coli MutHLS mismatch 
repair pathway; similar results were observed when Strep- 
tococcus pneumoniae HexA was expressed in E. coli. 
(Prudhomme et al., 1991). 
hMSH2 Is Located on Human Chromosome 2 
Two methods of analyzing the National Institute of General 
Medical Science (NIGMS) mapping panel 2, containing 
chromosome-specific cell hybrid DNAs, have been used 
to determine the chromosomal location of the hMSH2 
gene. The hMSH2 gene was localized to chromosome 2 
by Southern blot analysis. A commercially obtained blot 
and a probe specific to the original 360 bp PCR-generated 
clone were used in the initial analysis. The results showed 
that a single high molecular weight BamHl fragment (>23 
kb) present in DNA from the parental human cell line hy- 
bridized with the probe and that only the cell hybrid con- 
taining human chromosome 2 also contained this DNA 
fragment (data not shown). This was independently veri- 
fied in an experiment in which the human and hamster 
parental DNAs and the hamster-human chromosome 2 
cell hybrid DNA used to produce the NIGMS mapping 
panel 2 blot were digested with EcoRl and probed with 
both the original PCR-generated clone and the full-length 
cDNA clone (Figure 5A). In both cases, all of the homolo- 
gous DNA bands found in the human parental DNA could 
be accounted for in the cell hybrid containing human chro- 
mosome 2. 
The hMSH2 gene was also localized to chromosome 2 
using a PCR assay in which a pair of PCR primers was 
used specifically to amplify a portion of the human gene 
located in an intron site at nucleotide position 2020 of the 
cDNA. (A series of recombinant h phages covering the 
hMSH2genomic locus will bedescribed elsewhere.) PCRs 
contained individual NIGMS mapping panel 2 chromo- 
some-specific cell hybrid DNAs (Figure 58). A single ampli- 
fication product was obtained only from the parental hu- 
man DNA and the hamster-human chromosome 2 cell 
hybrid DNA. 
The Mouse Homolog Maps to Mouse Chromosome 
17 in a Region of Homology with Human 
Chromosome 2~22-21 
The map location of the hMSH2 gene was further refined 
by mapping the location of the mouse homolog. This was 
possible because the highly conserved region of human 
and mouse MSH2 contains large stretches of 100% amino 
acid identity and because the DNA sequence of this region 
contains segments as long as 85 bp that are 92% identical 
with the human DNA sequence. (The mouse Msh2 gene 
will be described elsewhere.) The mouse chromosomal 
location of MSHP was determined by interspecific back- 
cross analysis using progeny derived from matings of 
(C57BU6J x Mus spretus)Fl x C57BU6J mice. This in- 
terspecific backcross mapping panel has been typed for 
over 1400 loci that are well distributed among all the au- 
tosomes as well as the X chromosome (Copeland and 
Jenkins, 1991). C57BU6J and M. spretus DNAs were di- 
gested with several enzymes and analyzed by Southern 
blot hybridization for informative restriction fragment 
length polymorphisms using a human cDNA 360 bp 
hMSH2 probe to the most conserved region of MutS and its 
homologs. A 9.4 kb M. spretus Hindlll restriction fragment 
length polymorphism (see Experimental Procedures) was 
used to follow the segregation of the MshP locus in back- 
cross mice. The mapping results indicated that MshP is 
located in the distal region of mouse chromosome 17 
linked to anti-phosphotyrosine immunoreactive kinase 
(Tik), mouse homolog 1 of SOS (Msosl), and the lutropin- 
choriogonadotropin receptor (Lhcgr). Although 159 mice 
were analyzed for every marker and are shown in the seg- 
regation analysis (Figure 6), up to 191 mice were typed 
for some pairs of markers. Each locus was analyzed in 
pairwise combinations for recombination frequencies us- 
ing the additional data. The ratios of the total number of 
mice exhibiting recombinant chromosomes to the total 
number of mice analyzed for each pair of loci and the most 
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Figure 4. Expression of hMSH2 Causes a Dominant Mutator Phenotype in E. coli 
The frequency of spontaneous rif’ E. coli was measured by spotting 30 pl of saturated bacterial cultures onto plates containing ampicillin (total 
cells) or ampicillin plus rifampicin (rir’ mutants). All plates and cultures contained 0.5 mM isopropyl-6-D-thiogalactopyranoside to induce expression 
from the lac promoter. Three examples of plates exhibiting spontaneous rif’ colonies arising from bacterial cultures grown from independent 
transformant colonies (or isolated colonies, in the case of the E. coli mutS mutants) are shown. Two independent cultures of E. coli AB1157 mut.5 
show the magnitude of the mutator phenotype caused by a mutation inactivating the bacterial MutHLS mismatch repair system. The six other 
sectors of the top plate have independent cultures of wild-type E. coli AB1157 containing the Bluescript SK(+) vector without a cloned insert as 
a control for the frequency of spontaneous background mutations to rif’. The two bottom plates contain 16 independent cultures derived from 
independent transformants of E. coli AB1157 containing the pMSHl1 plasmid that contains the hMSH2 gene downstream of the lac promoter. 
likely gene order are as follows: centromere; Tik, l/162; 
Msosl, 3/I 61; MshP, 1 I1 91; Lhcgr. The recombination fre- 
quencies (expressed as genetic distances in centimor- 
gans 2 SEM)areTik,0.6 f 0.6;Msosl,1.9 f l.l;MshP, 
0.5 f 0.5; Lhcgr. 
We have recently found that the distal region of mouse 
chromosome 17 shares a region of homology with human 
chromosome 2p (summarized in Figure 6). In particular, 
Msosl has been placed on human 2~22-21 and Lhcgr 
has been placed on 2~21. The mapping of MshP between 
Msosl and Lhcgr suggests that the human homolog will 
map on the short arm of human chromosome 2 in the 
vicinity of band 21. 
The HNPCC locus has been mapped near human chro- 
mosome 2~16-15 by linkage to microsatellite markers (Pel- 
tomaki et al., 1993). HNPCC showed a high degree of 
linkage to a microsatellite polymorphism marker 028723. 
02S723 has been mapped 5 CM distal to D2S5, which has 
been localized to 2~16-15 by in situ hybridization, linkage, 
and somatic cell hybrid analysis (Peltomaki et al., 1993). 
HNPCC showed no linkage to D2S136, which is 14 CM 
proximal to 02S723, and a small degree of linkage to 
D2S779, which is 9 CM distal to 028723 (Peltomaki et al., 
1993). Our analysis of the published data suggests that 
the linkage of HNPCC to D2S779 was possibly greater 
than implied (Peltomaki et at., 1993), indicating that 
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Figure 5. MSHP Maps to Human Chromosome 2 
(A) Southern analysis of an EcoRl digest of total genomic DNA isolated 
from human cells, Chinese hamster cells, and hybrid Chinese hamster 
cells containing human chromosome 2. (8) PCR amplification of a 
specific fragment of hMSH2 from NIGMS mapping panel 2 DNAs. C, 
Chinese hamster parental genomic DNA; M, mouse parental genomic 
DNA; H, human parental DNA; MW, pBR322 BstNl digest molecular 
weight markers, 383 bp and 121 bp; 1, 2 22, X, Y, individual 
human-rodent cell hybrids containing chromosomes 1-22 and X and 
Y. Chromosomes 14, 18, 17, 20, and 21 are from mouse cell hybrids, 
and the remaining chromosomes are from Chinese hamster cell hy 
brids. The band marked MshP was amplified only when total human 
genomic DNA and genomic DNA from the human-hamster cell hybrid 
containing chromosome 2 were included in the PCR. 
HNPCC might map closer to 2~22-21 than the assigned 
2~16-15 location suggests. We are trying to confirm that 
hMSH2 is linked to 028723 by developing a microsatellite 
marker linked to hMSH2 so that linkage analysis with 
028123 can be performed. 
Association of hMSH2 and HNPCC 
HNPCC, also known as Lynch syndrome II and Muir-Torre 
syndrome (Bishop and Thomas, 1990) is one of the major 
types of hereditary colorectal cancer. HNPCC kindreds 
are defined as those in which three or more closely related 
family members in at least two successive generations 
have had histologically verified diagnosis of colorectal 
cancer, at least one of whom was diagnosed before 50 
years of age. Other tumors that are associated with the 
h8 87 I 0 I I 0 I 
0.6 
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1.9 
2Q22mQ21 
2p22-p21 
2p2l 
Figure 6. MshP Maps in the Distal Region of Mouse Chromosome 17 
Msh2 was placed on mouse chromosome 17 by interspecific backcross 
analysis. The segregation patterns of Msh2 and flanking genes in 159 
backcross animals that were typed for all loci are shown at the top of 
the figure. For individual pairs of loci, more than 159 animals were 
typed (see text). Each column represents the chromosome identified 
in the backcross progeny that was inherited from the (C57BU8J x 
M. spretus)Fl parent. The closed boxes represent the presence of a 
C57BU8J allele, and open boxes represent the presence of a M. 
spretus allele. The number of offspring inheriting each type of chromo- 
some is listed at the bottom of each column. A partial chromosome 
17 linkage map showing the location of MshP in relation to linked genes 
is shown at the bottom of the figure. Recombination distances between 
loci (in centimorgans) are shown to the left of the chromosome, and 
the positions of loci in human chromosomes, where known, are shown 
to the right. References for the human map positions of loci mapped 
in this study can be obtained from the Genome Data Base, a computer- 
ized data base of human linkage information maintained by The Wil- 
liam H. Welch Medical Library of The Johns Hopkins University (Balti- 
more, Maryland). 
syndrome occur elsewhere in the gastrointestinal tract, 
the female genital system, and the urinary tract. 
The close association of the hMSH2 gene and the HNPCC 
locus led us to search for hMSH2 mutations in HNPCC fami- 
lies. Because large chromosome 2-linked HNPCC kin- 
dreds were not immediately available to us, we have taken 
the approach of analyzing both sporadic tumors and small 
HNPCC (Figure 7) and HNPCC-like kindreds for hMSH2 
mutations using single-stranded conformational polymor- 
phism analysis, heteroduplex analysis, and direct DNA 
sequencing (Orita et al., 1989; Tassabehji et al., 1992; 
Gromp, 1993). Initially, we examined seven exons cov- 
ering the carboxy-terminal 48% of the MSH2 coding se- 
quence. Because of the limited analysis used in these 
experiments, we have clearly not conducted an exhaustive 
search for MSHP mutations. 
A collection of 26 paired DNA samples extracted from 
random colorectal tumors and matched normal tissues 
were analyzed for the presence of dinucleotide (CA), re- 
peat instability. Seven tumors were identified that showed 
dinucleotide repeat instability in at least one repeat locus. 
These seven tumor and paired normal DNA samples were 
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screened for MSH2 mutations. Two of the tumor DNAs 
were found to have a T to C transition mutation at the -6 
position of the splice acceptor site of the intron, located 
at nucleotide position 2020 of the cDNA sequence, that 
was not present in the matched normal DNA sample (Fig- 
ure 8). Similar T to C transition mutations within the poly- 
pyrimidine tract of mRNA splice acceptor sites, particularly 
short polypyrimidine tracts like the polypyrimidine tract 
of interest in hMSH2, have been shown to affect mRNA 
splicing (Roscigno et al., 1993). The remaining sequence 
of this region, including the coding sequences between 
nucleotides 2020-2225 and the intron splice donor site 
downstream of nucleotide position 2225, was identical to 
the sequence of the cloned genomic region. The sequence 
found in the remaining five pairs of normal and tumor DNAs 
was the wild-type sequence. When seven additional paired 
DNA samples from the original collection of 26 in which 
the tumor DNA did not show dinucleotide (CA), repeat 
instability were examined, the normal DNA sequence was 
found in DNA from all seven tumors and all seven of the 
paired normal tissue samples. A larger study of colon tu- 
mors and other tumor types will be required to determine 
the frequency of this and other potential hMSH2 mutations 
in different tumors. 
We have examined DNA from the blood of affected indi- 
viduals from nine small HNPCC and HNPCC-like kindreds 
for mutations, including the transition mutation described 
above. None of these kindreds have been tested for link- 
age to chromosome 2. Mutations were found in two classic 
HNPCC kindreds. We have observed that all three af- 
fected individuals tested from family 1 (see Figure 7) and 
both affected individuals tested from family 2 (see Figure 
7) are heterozygous for this T to C transition (Figure 8). 
Two individuals from family 1 who have not had cancer 
(ages 69 and 73) did not contain the mutation. We did not 
find a mutation in any of the other kindreds examined, but, 
as discussed above, we have not conducted an exhaustive 
Figure 7. Pedigrees of HNPCC Families 
Numbers above the symbols are patient identi- 
fiers: a plus indicates that a blood sample was 
analyzed. Numbers below the symbols are cur- 
rent ages unless they are listed with the sites 
of tumors, in which case they are the age of 
diagnosis. Letters represent the site of the tu- 
mor: AM, ampulla of vater; EL. bladder; CO, 
colorectal; DU, duodenum; OV, ovary; UT, 
uterus. All tissue diagnoses were confirmed by 
medical records. Adenomatous polyps were 
also identified in family 1 in patients II-1 and 
II-2 and occurred in patient l-2 at age 68. No 
medical history is available on individual I-1. In 
family 2, a brother of patient l-2 had died of 
colon cancer diagnosed at age 35, but archival 
material was not available for analysis. Also, 
one offspring of patient II-1 has had colonic 
adenomatous polyps diagnosed in the third de- 
cade. Each pedigree only represents a portion 
of a larger affected family; only the relevant 
portion of the family containing the affected in- 
dividuals analyzed is shown. 
search for mutations, leaving open the possibility that 
other MSHP mutations exist in these kindreds. We are 
now collecting additional DNA samples from other family 
members to conduct a more extensive analysis of these 
families. In addition, we are analyzing other kindreds, in- 
cluding large chromosome 2-linked kindreds, for the pres- 
ence of this and other hMSH2 mutations to determine 
whether hMSH2 mutations and HNPCC cosegregate. 
Discussion 
We have described the cloning of a human cDNAencoding 
a protein that is highly homologous to the S. cerevisiae 
MSH2 protein and that appears to be a member of a group 
of related proteins that includes the bacterial MutSlHexA 
proteins and the S. cerevisiae MSHl and MSH2 proteins. 
hMSH2 appears to be a member of a subgroup of these 
proteins, which have all been implicated as playing a role 
in the major mismatch repair pathway in these organisms. 
This is in contrast with the other two subgroups of MutSl 
HexA-related proteins, containing S. cerevisiae MSH3 and 
MSH4, respectively, for which there is little evidence that 
these proteins play a role in mismatch repair and in which 
mutations cause little if any mutator phenotype (New et al., 
1993; P. Ross-Macdonald and G. S. Roeder, unpublished 
data). The observation that the expression of the hMSH2 
protein in E. coli causes a dominant mutator phenotype 
similar to the heterologous expression of other divergent 
bacterial proteins provides support for the idea that 
hMSH2 functions in mismatch repair in humans. Because 
of the high degree of relatedness between hMSH2 and 
genes encoding proteins known to function in mismatch 
repair by recognizing mismatched bases, we postulate 
that hMSH2 protein plays a similar role in mismatch repair 
in humans. 
In addition to playing a major role in preventing muta- 
tions during DNA replication, the MutHLS-type mismatch 
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Figure 8. DNA Sequence of the mRNA Splice Acceptor Site Region 
of the lntron at Nucleotide Position 2020 of the cDNA 
(a [top strand]) and (d [bottom strand]) show the sequence of DNA 
from normal colon tissue; (b [top strand]) and (e [bottom strand]) show 
the sequence of DNA from a sporadic wlorectal tumor showing dinu- 
cleotide (CA). repeat instability; (c [top strand]) and (f [bottom strand]) 
show the sequence of DNA from blood of individual Ill-1 of family 1 
(Figure 7). The T to C transition is indicated by an asterisk and the 
intronlexon junction is indicated by an arrow. Analysis of the sequenc- 
ing chromalograms of the blood DNA samples from affected individu- 
als of the families shown in Figure 7 indicates that there is enough T 
signal in the C peak of the top strand and enough A signal in the 
G peak of the bottom strand to indicate that these individuals are 
heterozygous at this site. The T and A peaks are reduced relative to 
the C and G peaks owing to suppression of the T and A signals that 
occurs during sequencing through runs of Ts and As. 
repair systems also appear to regulate different types of 
genetic stability (Rayssiguier et al., 1969; Strand et al., 
1993). A striking example of this is that mutation of the 
msh2, mlh2, andpmsl genes all result in an increase in the 
rate of expansion and contraction of dinucleotide repeat 
sequences in S. cerevisiae of up to 700-fold (Strand et al., 
1993). This phenotype is similar to the destabilization of 
microsatellite repeated sequences associated with differ- 
ent types of cancer (lonov et al., 1993; Thibodeau et al., 
1993; Han et al., 1993; Risinger et al., 1993), including 
HNPCC (Lynch et al., 1991; Aaltonen et al., 1993), and 
provided the rationale for considering the possibility that 
hMSH2 might be the HNPCC gene. The presently avail- 
able data support the idea that the hMSH2 gene maps to 
human chromosome 2~22-21. This conclusion is based on 
experiments that locate hMSH2 on human chromosome 2, 
including experiments that map the mouse MSHP homolog 
to a region of the mouse genome that is homologous to 
human chromosome 2~22-21 and on the association be- 
tween a putative hMSH2 mRNA splice acceptor site muta- 
tion in both sporadic colon tumors and germline DNA from 
affected individuals of small HNPCC kindreds. Given the 
correspondence between the map location of hMSH2 and 
the map location of the HNPCC locus, our initial analysis 
of mutations in the hMSH2 gene, and the correspondence 
between the phenotypes of S. cerevisiae msh2 mutants 
and HNPCC, we suggest that mutations in the hMSH2 
gene are responsible for HNPCC. 
We have observed in both sporadic colon tumors and 
in germline DNA from affected individuals of HNPCC kin- 
dreds a T to C transition mutation at the -6 position of 
the splice acceptor site of the intron located at nucleotide 
position 2020 of the cDNA sequence. This is the splice 
acceptor site in the intron in front of the exon encoding 
the most conserved region of the protein. The observation 
of independent occurrences of the same mutation in two 
sporadic tumors and two unrelated families was unex- 
pected. Our sample size is not large enough to prove defin- 
itively a link to HNPCC; however, the observation of this 
mutation in tumor tissue, but not normal tissue of the same 
individual, provides a strong indication that this base 
change represents a mutation rather than a polymor- 
phism. A largerstudyof both sporadic tumors and HNPCC 
kindreds will be required to establish more firmly that the 
observed base change is not a polymorphism and to estab- 
lish an association of this mutation and other hMSH2 muta- 
tions with both HNPCC and sporadic cancers. In this re- 
gard, we have recently examined two affected and two 
unaffected individuals from a chromosome 2-linked 
HNPCC family (Bishop and Thomas, 1990). Both affected 
individuals had the T to C transition mutation, whereas 
both unaffected individuals had the wild-type sequence 
(D. T. Bishop, N. Hall, J. Burn, M. K., and R. K., unpub- 
lished data). 
The observation of a putative mRNA splice acceptor site 
mutation is intriguing. De la Chappelle, Vogelstein, and 
their collaborators have shown that HNPCC is apparently 
not associated with loss of heterozygosity (Peltomaki et 
al., 1993). This suggests that HNPCC mutations may be 
dominant. If the putative mRNA splice acceptor site muta- 
tion causes exon skipping or some other type of aberrant 
mRNA processing, then a truncated protein or a protein 
in which some internal sequences are deleted might result. 
The expression of such a protein might cause a dominant 
negative effect by interfering with the normal mismatch 
repair machinery, much like that observed when hMSH2 
(Figure 4) and HexA are expressed in E. coli (Prudhomme 
The Human Mutator Gene MSHL 
1035 
et al., 1991). Testing this hypothesis will require proving 
that the mutation observed actually affects mRNA splicing, 
that a mutant protein is synthesized, and that it interferes 
with normal mismatch repair. 
Several lines of evidence have suggested that cancers 
require multiple oncogene mutations to produce a meta- 
static tumor (Renan, 1993). For example, six independent 
mutations have been documented for the development of 
colon tumors (Fearon and Vogelstein, 1990). This number 
of mutations appears to be excessively high to be ac- 
counted for by the normal frequency of spontaneous muta- 
tions in cells. A role for hMSH2 in the development of 
cancer would suggest that a defect in the mismatch repair 
system may lead to an increased rate of accumulation of 
spontaneous mutations. This increased mutation rate and 
associated genome instability would then underlie the de- 
velopment of HNPCC and sporadic cancers. We further 
suggest that mutations in any of the other genes in an 
MSHP-dependent mismatch repair pathway could also 
cause a high frequency of mutagenesis that leads to the 
accumulation of such mutations. Furthermore, a common 
feature of tumor cells is the gross rearrangement of geno- 
mic DNA, including chromosome loss and rearrangement 
(Reichmann et al., 1981; Visscher et al., 1990). It is possi- 
ble that a loss of hMSH2 function could increase the fre- 
quency of homeologous recombination between divergent 
DNA sequences, leading to chromosome rearrangements. 
In summary, we have described a gene that is a candi- 
date to be the HNPCC gene. Homologs of this gene en- 
code a protein that functions in mismatch repair. Taken 
together, these statements make a number of predictions. 
First, the hMSH2 protein should specifically bind to DNA 
containing mispaired bases. Second, mutations in the 
hMSH2 gene should cosegregate with cancers in large 
HNPCC families. Third, mutations in the hMSH2 gene 
should be common in sporadic colon tumors and in other 
tumors that show dinucleotide repeat instability. It is also 
possible that mutations in the hMSH2gene will be found in 
tumors showing the types of genetic instability associated 
with homeologous recombination events. We would like 
to point out that mutations in otherhMSHP-dependent mis- 
match repair pathway genes might also cause the same 
effects as mutations in hMS/-/P. Finally, it is also possible 
that we may find mutations in the hMSH2 gene or related 
pathway genes to be associated with sporadic occur- 
rences of inherited diseases, such as fragile X syndrome 
(Kuhl and Caskey, 1993), caused by the expansion of re- 
peated sequences. 
Experimental Procedures 
Chemicals, Enzymes, Oligonucleotldes, DNAs, 
Libraries, and Vectors 
Ultrapure Tris (acid and base), EDTA, MgCL MgSO,, NaCI, and analyt- 
ical grade sodium citrate, KCI, potassium phosphate monobasic 
(KH2P04), and sodium phosphate dibasic (N&HPO,) were obtained 
from Amresco (Solon, Ohio). Ultrapure glycerol was obtained from 
Mallinckrodt, Incorporated (Paris, Kentucky). Deoxyribonucleoside tri- 
phosphates and ATP were purchased from Pharmacia LKB Biotech- 
nology, Incorporated (Uppsala, Sweden). NIGMS mapping panel 2 
DNAs were from Coriell Cell Ftespositories (Camden, New Jersey), 
and a Southern transfer of a BamHl digest of these DNAs used in 
preliminary experiments was from Oncor (Gaithersburg, Maryland). 
Gelatin was purchased from Sigma (St. Louis, Missouri). Restriction 
endonucleases, calf intestinal phosphatase, T4polynucleotide kinase, 
and T4 DNA ligase were purchased from New England Biolabs, Incor- 
porated (Beverly, Massachusetts). Taq polymerase was purchased 
from Perkin-Elmer Cetus (Norwalk, Connecticut). [a-‘*P]dCTP and 
[r-32P]rATP were purchased from Amersham (Arlington Heights, Illinois). 
Oligonucleotides were synthesized on an Applied Biosystems (Foster 
City, California) 394 DNA synthesizer and were deprotected and puri- 
fied by standard methods. PCR products of hMSH2 were inserted into 
BarnHI-digested Bluescript SK(+) vector DNA (Stratagene, La Jolla, 
California) using standard methods. Isolation of the hMSH2 cDNA 
clone (pMSH11) was done by screening a HeLa S3 cDNA library con- 
structed in the UniZap vector system (Stratagene, La Jolla, California). 
Plating and screening the library were performed according to the 
recommendations of the manufacturer. 
Cloning AMSH2 Using Degenerate PCR 
Degenerate oligonucleotides that would hybridize to DNA encoding 
two highly conserved regions of the known bacterial MutS/HexA and 
S. cerevisiae MSH proteins were designed along the lines described 
by Reenan and Kolodner (1992a). The following amino acid regions 
were selected: primer la, FATH(F/Y) (noncoding strand) 5%GC- 
GGATCC (G/A)(A/T)A (G/A)TG (G/A/T/C)GT (GIAfVC)GC (GIA)AA-3’; 
primer 1 b, FTTH(F/Y) (noncoding strand) 5’-CGCGGATCC (G/A) 
(A/T)A (AfG)TG (G/m/C)GT (G/AIl/C)GT (G/A)AA-3’; primer lc, 
FVTH(FY) (noncoding strand) 5’CGCGGATCC (G/A)(mA (G/A)TG 
(G/A/T/C)GT (G/A/T/C)AC (A/G)AAd’; and primer 2, TGPNM (coding 
strand) S’CGCGGATCC AC(GIAJTIC) GG(GIAlTIC) CC(G/AKlC) AA- 
(T/C) ATG-3’. The CGCGATCC sequence at the 5’ end of each oligo- 
nucleotide is the BamHl restriction enzyme cleavage site added to 
facilitate cloning of the amplification product into the Bluescript SK(+) 
vector. PCR amplification of known MSH sequences from yeast geno- 
mic DNA was used to optimize the PCR conditions using primer 2 
paired with either primer la, 1 b, or lc. PCR was performed in a 50 PI 
volume containing 10 mM Tris (pH S.3), 50 mM KCI, 0.01% gelatin, 
200 pM each of dGTP, dATP, dTTP, and dCTP, 1 U of Taq DNA 
polymerase, and 25 pmol of each degenerate primer. Multiple concen- 
trations of MgSO& were tested (1 mM, 3 mM, 5 mM, and 10 mu) for 
each primer pair as well as multiple concentrations of yeast genomic 
DNA or human cDNA (10 ng, 100 ng, and 1 vg). Human cDNA was 
prepared by standard methods from mRNA purified from HPB-ALL 
cells (Moore and Fishel, 1990) using the mRNA purification kit (Phar- 
macia, Uppsala, Sweden). The optimal method for amplification using 
these degenerate oligonucleotides on cDNA was found to be 35 cycles 
of denaturation for 1 min at 94OC, of annealing for 2 min at 45OC, and 
of polymerization for 5 min at 72OC. 
After electrophoretic analysis of the products on a 2% agarose gel 
run in TAE buffer (45 mM Tris [pH 6.01, 5 mM sodium acetate, 2 mM 
EDTA), reactions that were deemed to contain products of the ex- 
pected size (360 bp) were extracted with buffered phenol, precipitated 
in ethanol, and fractionated on a preparative 2% agarose-TAE gel 
containing 0.5 fig/ml ethidium bromide (Sigma, St. Louis, Missouri). 
The DNA band of interest was then isolated from the gel using NA45 
paper essentially as described by the manufacturer (Schleicher 8 
Schuell, Keene, New Hampshire) with the modification that the DNA 
was eluted from the NA45 paper by incubation at 70°C for 1 hr in 300 
PI of 1 M NaCI, 50 mM arginine (free base). The elution solution was 
removed and extracted with buffered phenol, and the DNA was precipi- 
tated with ethanol. This isolated DNA fragment was digested with 
BamHl and reisolated from a 2% agarose-TAE gel using NA45 paper, 
as described above, to remove the linker. The Bluescript SK(+) vector 
was digested with BamHI, treated with 20 U of calf intestinal phospha- 
tase in a 50 pl reaction, and isolated from a 1% agarose gel using 
NA45 paper as described above. Fragment (20 ng) and Bluescript 
vector (200 ng) were added to a ligation reaction (100 pl) containing 
50 mM Tris (pH 7.6), 6 mM MgCI,, 5 mM 6-mercaptoethanol, 67 pM 
ATP, and 40 U of T4 DNA ligase and were incubated at 12.5V for 
16 hr, and then the DNA was transformed into E. coli XL1 blue (Stra- 
tagene, La Jolla, California) by the standard Mg2+-Ca2+ transformation 
procedure (Sambrook et al., 1969). Small-scale preparations of plas- 
mid DNA (Sambrook et al., 1989) from individual transformants were 
analyzed for the presence of the appropriately sized insert (360 bp), 
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and IO such clones generated with each primer pair were analyzed 
by double-stranded DNA sequencing. We found one MSH2 homolog 
among the 10 clones generated with the primer la plus primer 2 pair, 
and this plasmid was designated pMSH22. 
The MSH2 homolog sequence contained in pMSH22 was used as 
a probe to screen a human cDNA library (UniZap HeLa S3 cDNA, 
Stratagene, La Jolla, California) according to the recommendations 
of the manufacturer. Oligonucleotide primers 15996 (5”GTGATA- 
GTACTCATGGCC) and 15607 (5’-AGCACCAATCTTTGTTGC) were 
designed to hybridize to nucleotides inside the degenerate primer se- 
quences on both ends of the f&HP sequences present in pMSH22. 
A 276 bp fragment was amplified by PCR using these primers and 
was purified using NA45 paper as described above. A radiolabeled 
probe was made by performing PCR using 25 cycles of denaturation 
for 1 min at 94%, of annealing for 2 min at 50°C, and of polymerization 
for 2 min at 72’% with a 50 ~1 reaction containing 1.5 mM MgSO,, IO 
ng of the isolated 276 bp fragment, 200 pM each of dATP, dGTP, and 
dlTP, 25 pmol each of the two primers (15998 and 15607) and 100 
t&i of [@P]dCTP (5000 Cilmmol). Unincorporated nucleotides were 
removed by chromatography on a nick column (Pharmacia, Uppsala, 
Sweden), the probe was denatured by boiling for 5 min, and 1 x 10’ 
to 1 x lOBtotal disintegrations per minute were used to probe Hybond 
N+ filters (Amersham, Arlington Heights, Illinois) containing 1 UniZap 
HeLa S3 cDNA plate lifts (106 members). Two additional screens were 
carried out to isolate a homogeneous h UniZap HeLa S3 cDNA phage 
population, and the insert was rescued using the R408 helper filamen- 
tous phage as described by the manufacturer (Stratagene, La Jolla, 
California). One positive clone containing a large 3111 bp cDNA insert 
with a 2727 bp open reading frame homologous to MSH2 was charac- 
terized by DNA sequencing and designated pMSHl1. 
DNA Sequence Analysis 
DNA sequencing of double-stranded plasmid DNAs was done with 
an Applied Biosystems (Foster City, California) 373A DNA sequencer 
using standard protocols and dye-labeled dideoxy nucleoside triphos- 
phates as terminators (Sanger et al., 1977; Smith et al., 1966). DNA 
sequence alignments and contigs were constructed using Sequencher 
2.0.10 (Gene Codes Corporation, Ann Arbor, Michigan). Data base 
(NCBI-GenBank release 76, PIR release 37, and SwissProt release 
26) searches were performed at the National Center for Biotechnology 
Information using the basic local alignment search tool (BLAST) net- 
work service (Altschul et al., 1990). DNA and protein sequence homol- 
ogy alignments were performed using DNAStar MegAlign using the 
CLUSTAL method (Higgins et al., 1992). Multiple alignment parame- 
ters were a gap penalty of 10 and a gap length penalty of IO. Pairwise 
alignment parameters were a ktuple of 1, gap penalty of 3, window of 
5, and diagnols saved of 5. The phylogenetic tree was also constructed 
using DNAStar MegAlign (Rzhetsky and Nei, 1992). 
Southern Hybridization 
NIGMS mapping panel 2 DNAs were digested with EcoRI, and 10 ug 
of the resulting genomic DNA fragments was separated by electropho- 
resis through a 1% agarose gel run in TAE buffer. Southern transfer 
was performed according to Sambrook et al. (1969) onto Hybond N’ 
paper. Probe was prepared using the PCR method described above 
except that primers were used that amplify the full-length hMSH2 frag- 
ment. We have found that this probe identifies EcoRl fragments con- 
taining the largest exons but does not identify all of the genomic EcoRl 
fragments containing MSM exons, presumably because of underrep- 
resentation in the probe of some MSH2 sequences from the central 
portion of the insert (data not shown). The Southern blot data shown 
in Figure 5 were independently verified in experiments in which blots 
were hybridized with different probes specific to subregions of MSHP 
covering all of the MSH2 coding sequence (data not shown). 
PCR Mapping 
PCR was used to detect MSH2 sequences in the NIGMS mapping 
panel of DNAs using primers 16388 (5’-GTTTTTCCTTTCATCCGTTG) 
and 16389 (5’~AAACTAGCCAGGTATGG) that amplify a predicted 158 
bp fragment of t&HP contained in an intron located at nucleotide 
position 2020 of the cDNA sequence. PCRs (25 ul) contained IO mM 
Tris buffer (pH 6.5) 50 mM KCI, 3 mM MgC12, 0.01% gelatin, 50 pM 
each of dGTP, dATP, dTTP, and dCTP, 1.5 U of Taq DNA polymerase, 
5 pmol of each primer, and 0.5 trg of each DNA sample. PCR was 
performed for 30 cycles of denaturation for 30 s at 94OC, of annealing 
for 30 s at 55%, and of polymerization for 1 min at 72%. and 3 nl 
of each reaction was analyzed by electrophoresis through a 1.4% 
agarose gel run in TAE buffer. 
Analysis of the MSH2 Gene for Mutations 
The coding sequence from nucleotide positions 2020-2225 of the 
cDNA and the flanking regions of the genomic DNA containing the 
intronlexon junctions were amplified by PCR using primers 16324 
(5”CGCGAlTAATCATCAGTG) and 16340 (5’-GGACAGAGACATA- 
CATTTCTATC). PCR was as described for PCR mapping except that 
the reactions contained 25 ng of DNA, 0.1 pCi of [a-32P]dCTP and 
were performed for 35 cycles. The resulting PCR products were then 
analyzed by single-stranded conformational polymorphism analysis 
and heteroduplex analysis using standard methods (Orita et al., 1969; 
Tassabehji et al., 1992; Gromp, 1993). Direct sequence analysis was 
performed by preparing unlabeled PCR products using the same 
method, purifying the PCR product by the GeneClean method (BIO 
101. Incorporated, La Jolla, California), and then sequencing the prod- 
ucts using primers 18324 and 16340 as described under DNA se- 
quence analysis. DNAfrom tumor/normal pairs was analyzed for dinu- 
cleotide (CA), repeat instability using microsatellite markers 029123 
and 02.9 79 and standard methods. 
Two types of DNA samples were analyzed. DNA samples prepared 
from the blood of both affected and unaffected individuals from small 
kindreds who appeared to have Lynch syndrome II and Muir-Torre 
syndrome were provided by F. Li and S. Verselis (Dana-Farber Cancer 
Institute, Boston). These samples were provided without identification 
and were only identified after the analysis was complete. A collection 
of matched DNAs extracted from a random assortment of colorectal 
tumors and adjacent normal tissue was provided by M. Barrett, J. M. 
Jessup, andG. Steele, Jr. (New England Deaconess Hospital, Boston). 
The identification of the tumor and normal DNAs was provided prior 
to analysis, but the diagnosis of individual tumor types was provided 
after the analysis was complete. 
Interspecific Backcross Mouse Mapping 
Interspecific backcross progeny were generated by mating (C57BU6J 
x M. spretus)Fl femalesandC57BU6J malesas described (Copeland 
and Jenkins, 1991). A total of 205 N2 mice were used to map the Msh2 
locus (see text for details). DNA isolation, restriction enzyme digestion, 
agarose gel electrophoresis, Southern blot transfer, and hybridization 
were performed essentially as described (Jenkins et al., 1982). All 
blots were prepared with Zetabind nylon membrane (AMF Cuno, Leval- 
lois-Perret, France). The probe, a 360 bp human cDNA clone, was 
labeled with [@P]dCTP using a random-primed labeling kit (Stra- 
tagene, La Jolla, California); washing was done to a final stringency 
of 1.0 x SSCP, 0.1% SDSat 65OC. Afragmentof 12.5 kbwasdetected 
in Hindlll-digested C57BU6J DNA, and a fragment of 9.4 kb was de- 
tected in Hindlll-digested M. spretus DNA. The presence or absence 
of the 9.4 kb M. spretus-specific Hindlll fragment was followed in 
backcross mice. A description of the probe and the restriction fragment 
length polymorphisms for one of the loci linked to MshP and Msosl has 
been reported (Webb et al., 1993). One locus not previously reported is 
Tik (Icely et al., 1991). The probe was a 1733 bp BamHl fragment of 
mouse cDNA that detected 14.0, 6.1, 3.7, and 1.5 kb fragments in 
Seal-digested C57BU6J DNA and 7.3, 5.6, 2.9, 2.1, and 1.5 kb frag- 
ments in Seal-digested M. spretus DNA. The other locus not previously 
reported for this cross is Lhcgr (McFarland et al., 1969). The probe 
was an 622 bp fragment of rat cDNA that detected major fragments 
of 13.5 and 8.3 kb in C57BU6J DNA and of 8.3, 7.1, and 3.1 kb in M. 
spretus DNA following digestion with Bgll. The M. spretus-specific 
restriction fragment length polymorphisms cosegregated and were 
followed in this analysis. Recombination distances were calculated 
as described (Green, 1961) using the computer program SPRETUS 
MADNESS. Gene order was determined by minimizing the number 
of recombination events required to explain the allele distribution pat- 
terns. 
Mutator Assay 
The rate of spontaneous mutation to if’ in wild-type E. coli AB1157 
(F-, thrl. leu6, thil, lacyl, galK4, ara14, xy15, mtll, proA2, his4, argE3, 
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sfr37, &x33, supE44, X) was determined using a plate assay. The 
hMSH2 containing Bluescript (Stratagene, La Jolla, Calfornia) plasmid 
derivative pMSHl1 was transformed into AB1157 according to the 
procedure of Fishel et al. (1986). Ampicillin-resistant transformants 
were selected and grown to saturation in LB buffer containing 100 ug/ 
ml ampicillin and 0.5 mM isopropyl-8-D-thiogalactopyranoside. Dilu- 
tions of this culture were plated on LB plates containing 100 uglml 
ampicillin to determine the total number of viable cells containing the 
pMSHl1 plasmid and on LB plates containing 100 uglml ampicillin 
plus 100 pglml rifampicin (Sigma, St. Louis, Missouri) to determine 
the total number of spontaneous rif’ mutants in the culture. The rate 
of mutation was calculated according to Lea and Coulson (1949) using 
r, = M(1.24 + 1 n M), where r, is the median number of rif’ mutations 
in an odd number of independent cultures (usually 15) and M is the 
average number of rif’mutations per culture. M wassolved by interpola- 
tion from the known r0 value and then used to calculate the mutation 
rate r. where r = M/N, where N is the final average number of viable 
cells. 
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